Benedict Ciszek, MD
Family Medicine · Chicago, ILNPI 1881898617
Payments from drug & device makers
Across 75 payments — averaging $29.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$331
- Corcept Therapeutics$321
- Novo Nordisk$246
- Spinal Simplicity, LLC$181
- Lundbeck LLC$159
- Pfizer$146
- plus $849 from 23 others
What the payments were for
- Speaking & faculty fees$151%
- Food & beverage$2,21999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 2 | $331 |
| Corcept Therapeutics | 10 | $321 |
| Novo Nordisk | 11 | $246 |
| Spinal Simplicity, LLC | 1 | $181 |
| Lundbeck LLC | 8 | $159 |
| Pfizer | 6 | $146 |
| Lilly USA, LLC | 5 | $144 |
| Eisai Inc. | 4 | $98 |
| AstraZeneca | 3 | $68 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| Bayer | 2 | $49 |
| Exact Sciences | 2 | $40 |
| Cleerly, Inc. | 2 | $40 |
| GSK | 2 | $33 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Amgen | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $24 |
| Intuitive Surgical | 1 | $22 |
| C2n Diagnostics, LLC | 1 | $22 |
| Edwards Lifesciences | 1 | $21 |
| Biogen | 1 | $21 |
| Baxter Healthcare | 1 | $20 |
| Lucid Diagnostics Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Philips North America LLC | 1 | $15 |
| Medicure Pharma Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ETERNA$331
- HA MINUTEMAN G3-R$181
- Korlym$113
How this compares
$2,234 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 34 | $61,455 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 12 | $55,415 |
| EliquisApixaban | 44 | $54,919 |
| XareltoRivaroxaban | 15 | $17,179 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $6,621 |
| Atorvastatin Calcium | 330 | $3,207 |
| Metoprolol Succinate | 151 | $2,374 |
| Advair DiskusFluticasone Propion/Salmeterol | 11 | $2,221 |
| Lisinopril | 245 | $2,088 |
| Levothyroxine Sodium | 160 | $1,984 |
| Amlodipine Besylate | 205 | $1,723 |
| SynthroidLevothyroxine Sodium | 14 | $1,425 |
| Gabapentin | 57 | $1,419 |
| Losartan Potassium | 160 | $1,416 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 45 | $1,283 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $246 | $61,45534 claims |
| PfizerEliquis | $146 | $54,91944 claims |
| GSKBreo Ellipta | $33 | $6,62117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Chicago
- Bradley TorphyChicago$3M
- Frank PhillipsChicago$1.6M
- Ayoade AkereChicago$484K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
- Jacqueline OlivoChicago$165K
- Sameer PanjwaniChicago$136K
- Igor AltmanChicago$64K
- Juan RojasChicago$40K
- Mark SimonChicago$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.